Extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis

K Ramanathan, K Shekar, RR Ling, RP Barbaro… - Critical care, 2021 - Springer
Background There are several reports of extracorporeal membrane oxygenation (ECMO)
use in patients with coronavirus disease 2019 (COVID-19) who develop severe acute …

ECMO in COVID-19 patients: a systematic review and meta-analysis

P Bertini, F Guarracino, M Falcone, P Nardelli… - Journal of cardiothoracic …, 2022 - Elsevier
Objective To analyze the survival rates of patients with COVID-19 supported with
extracorporeal membrane oxygenation (ECMO) and compare the survival rates of patients …

Clinical characteristics between survivors and nonsurvivors of COVID-19 patients requiring extracorporeal membrane oxygenation (ECMO) support: a systematic …

WH Chong, BK Saha… - Journal of intensive care …, 2022 - journals.sagepub.com
Background: The use of extracorporeal membrane oxygenation (ECMO) in coronavirus
disease 2019 (COVID-19) for refractory respiratory failure, severe cardiac dysfunction, and …

A systematic review and meta-analysis comparing the clinical characteristics and outcomes of COVID-19 and influenza patients on ECMO

WH Chong, BK Saha, BI Medarov - Respiratory Investigation, 2021 - Elsevier
Background Extracorporeal membrane oxygenation (ECMO) is a valuable rescue therapy to
treat refractory hypoxemia caused by influenza. The present meta-analysis aimed to …

Hydrotalcite–niclosamide nanohybrid as oral formulation towards SARS-CoV-2 viral infections

G Choi, H Piao, NS Rejinold, S Yu, K Kim, G Jin… - Pharmaceuticals, 2021 - mdpi.com
COVID-19 has been affecting millions of individuals worldwide and, thus far, there is no
accurate therapeutic strategy. This critical situation necessitates novel formulations for …

Extracorporeal membrane oxygenation in COVID-19 compared to other etiologies of acute respiratory failure: A single-center experience

H Yaqoob, D Greenberg, L Huang, T Henson… - Heart & Lung, 2023 - Elsevier
Background The COVID-19 pandemic has led to a boom in the use of VV ECMO for ARDS
secondary to COVID. Comparisons of outcomes of ECMO for COVID to ECMO for influenza …

[HTML][HTML] Extracorporeal membrane oxygenation for COVID-19: a systematic review

RS Aljishi, AH Alkuaibi, FA Al Zayer, AH Al Matouq - Cureus, 2022 - ncbi.nlm.nih.gov
COVID-19 may result in acute respiratory distress (ARDS) in patients with the severe form of
the disease. Extracorporeal membrane oxygenation (ECMO) can support respiratory gas …

Outcomes of COVID-19 patients undergoing extracorporeal membrane oxygenation: A systematic review and meta-analysis

S Jiang, P Yan, Z Ma, J Liang, Y Hu, J Tang - Perfusion, 2023 - journals.sagepub.com
Background The Coronavirus Disease 2019 (COVID-19) pandemic has been ongoing for
over 3 years, during which numerous clinical and experimental studies have been …

Relationship between the Pre-ECMO and ECMO Time and Survival of Severe COVID-19 Patients: A Systematic Review and Meta-Analysis

Z Tan, L Su, X Chen, H He, Y Long - Journal of Clinical Medicine, 2024 - mdpi.com
Background: Coronavirus disease 2019 (COVID-19) is the etiology of acute respiratory
distress syndrome (ARDS). Extracorporeal membrane oxygenation (ECMO) is used to …

[HTML][HTML] Outcome of patients receiving VV ECMO for SARS-CoV-2 severe acute respiratory failure

IS Morris, H Taylor, D Fleet, FY Lai, M Charlton… - …, 2023 - ncbi.nlm.nih.gov
TaggedPDespite offering a potentially lifesaving intervention for severe acute respiratory
failure (SARF), venovenous (VV) ECMO is a highly invasive and costly resource that is itself …